FDA Approves Caplyta for Major Depressive Disorder in Adults

THURSDAY, Nov. 13, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressa